Ardent Health Partners, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
13.90
-0.94 (-6.33%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ardent Health Partners Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Ardent Health Partners stock have an average target of 21.55, with a low estimate of 18 and a high estimate of 25. The average target predicts an increase of 55.04% from the current stock price of 13.90.
Analyst Consensus: Buy
* Price targets were last updated on Jan 21, 2025.
Analyst Ratings
The average analyst rating for Ardent Health Partners stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Hold | 1 | 1 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $24 → $22 | Buy | Maintains | $24 → $22 | +58.27% | Jan 21, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | +51.08% | Jan 6, 2025 |
| JP Morgan | JP Morgan | Hold Initiates $20 | Hold | Initiates | $20 | +43.88% | Dec 17, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $23 | Buy | Reiterates | $23 | +65.47% | Nov 14, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $23 → $25 | Buy | Maintains | $23 → $25 | +79.86% | Nov 12, 2024 |
Financial Forecast
Revenue This Year
5.96B
from 5.41B
Increased by 10.18%
Revenue Next Year
6.42B
from 5.96B
Increased by 7.77%
EPS This Year
1.23
from 0.11
Increased by 1,006.26%
EPS Next Year
1.98
from 1.23
Increased by 60.61%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 6.2B | 6.7B | 7.1B |
| Avg | 6.0B | 6.4B | 6.8B |
| Low | 5.7B | 6.0B | 6.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 13.7% | 12.0% | 10.0% |
| Avg | 10.2% | 7.8% | 6.1% |
| Low | 5.7% | 1.4% | 1.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.37 | 2.25 | 2.58 |
| Avg | 1.23 | 1.98 | 2.20 |
| Low | 1.03 | 1.77 | 1.92 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1,128.0% | 82.7% | 30.8% |
| Avg | 1,006.3% | 60.6% | 11.4% |
| Low | 831.0% | 44.2% | -2.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.